Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 4, 2007, Pages 172-178

  Teramura, Megumi ^a   Emoto, Masanori ^a   Araki, Takahiro ^a   Yokoyama, Hisayo ^a   Motoyama, Koka ^a   Shinohara, Kayo ^a   Mori, Katsuhito ^a   Koyama, Hidenori ^a   Shoji, Tetsuo ^a   Inaba, Masaaki ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intima media thickness (IMT); Metabolic syndrome; Stiffness parameters ; Type 2 diabetes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CAROTID ARTERY; CAROTID ARTERY DISEASE; ECHOGRAPHY; ETHNOLOGY; FEMALE; HUMAN; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTOR; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 38449101993     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E505     Document Type: Article

References (35)

1. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, and Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 2003; 108:414-419
2. Alexander CM, Landsman PB, Teutsch SM, and Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes, 2003; 52:1210-1214
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, and Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001; 24:683-689
4. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, and Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 2002; 288:2709-2716
5. Zimmet P, Alberti KG, and Shaw J: Global and societal implications of the diabetes epidemic. Nature, 2001; 414:782-787
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285:2486-2497
7. Kahn R, Buse J, Ferrannini E, and Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2005; 28:2289-2304
8. Matsuzawa Y: Metabolic syndromc-definition and diagnostic criteria in Japan. J Atheroscler Thromb, 2005; 12:301
9. Ko GT, Chan JC, Cockram CS, and Woo J: Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord, 1999; 23:1136-1142
10. Ota T, Takamura T, Hirai N, and Kobayashi K: Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care, 2002; 25:1252-1253
11. Lear SA, Chen MM, Frohlich JJ, and Birmingham CL: The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. Metabolism, 2002; 51:1427-1432
12. Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, and Yamane Y: The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health, 2003; 45:335-343
13. Oh JY, Hong YS, Sung YA, and Barrett-Connor E: Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care, 2004; 27:2027-2032
14. Tan CE, Ma S, Wai D, Chew SK, and Tai ES: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004; 27:1182-1186
15. IDF: web cite: http://wwwidforg/webdata/docs/ Metabolic_syndrome_definitionpdf,
16. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, and Shaw J: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb, 2005; 12:295-300
17. Hulthe J, Bokemark L, Wikstrand J, and Fagerberg B: The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol, 2000; 20:2140-2147
18. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, and Lakatta EG: Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol, 2004; 43:1388-1395
19. Iglseder B, Cip P, Malaimare L, Ladurner G, and Paulweber B: The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke, 2005; 36:1212-1217
20. Fan AZ: Metabolic syndrome and progression of atherosclerosis among middle-aged US adults. J Atheroscler Thromb, 2006; 13:46-54
21. Kawamoto R, Tomita H, Oka Y, Ohtsuka N, and Kamitani A: Metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. J Atheroscler Thromb, 2005; 12:268-275
22. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, Yamamoto Y, and Yamashina A: Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension, 2005; 45:997-1003
23. New criteria for 'obesity disease' in Japan. Circ J, 2002; 66:987-992
24. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, and Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97:1837-1847
25. Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H, Izumotani K, Shoji T, Ishimura E, Inaba M, Okuno Y, and Morii H: Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care, 1998; 21:1178-1182
26. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004; 363:157-163
27. Heng D, Ma S, Lee JJ, Tai BC, Mak KH, Hughes K, Chew SK, Chia KS, Tan CE, and Tai ES: Modification of the NCEP ATPIII definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis, 2006; 186:367-373
28. Definition and the diagnostic standard for metabolic syndrome-Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zasshi, 2005; 94:794-809
29. Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T, and Shimamoto K: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. Hypertens Res, 2005; 28:203-208
30. Ford ES, Giles WH, and Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 2002; 287:356-359
31. Scuteri A, Najjar SS, Morrell CH, and Lakatta EG: The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care, 2005; 28:882-887
32. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, and Visseren FL: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J, 2004; 25:342-348
33. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, and Haffner SM: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care, 2004; 27:2676-2681
34. Wannamethee SG, Shaper AG, Lennon L, and Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med, 2005; 165:2644-2650
35. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, and Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res, 2005; 28:27-34